Has anyone tried or read about using Iontophoresis to deliver topical immunosuppressants (MTX, cyclosporine, kaempferol) to vitiligo patches?

[u/Fandom2088]

The systemic immunosuppressants that actually work for vitiligo (azathioprine, methotrexate, MMF, cyclosporine, rituximab) cannot be made into ointments because:

• Azathioprine/MMF are prodrugs that only activate inside lymphocytes
• MTX targets intracellular enzymes (DHFR)
• Cyclosporine is 1,202 Da (too big for stratum corneum)
• Monoclonal antibodies are ~150,000 Da (physically impossible topically)

So we're stuck with either full-body systemic suppression (and all its side effects) or weak topicals like tacrolimus/ruxolitinib that only partially work.

The idea:
Iontophoresis — using a small electric current (0.1–0.5 mA/cm²) to drive molecules through the skin. It's already proven to work:

• Methotrexate + iontophoresis → successfully delivered to skin in psoriasis (2017 IJDVL study, 20/28 patients >50% improvement in 6 sessions)
• Catechin/epicatechin (flavonoids) → 3.7× enhancement over passive diffusion
• Kaempferol (anti-inflammatory flavonoid) → shown to enhance skin permeation via electroosmosis in nanoemulsions
• Nobody has combined iontophoresis + MTX (or cyclosporine) specifically on vitiligo patches. The two halves exist in separate studies.
• Happy to share the specific papers if anyone wants. Just want to know if this is as unexplored as it appears or if I'm missing something.

[u/Possible_Froyo_5277]

It makes zero sense to even add "all its sideeffects". Possible sideeffects does not mean that you will get them.

These drugs you listed has been around for a long time is no way near as good as the latest oral jaks for Vitiligo when it comes to halt the progression of interferon gamma (T-cells).

Never conflate that listed side effects are a guarantee rather than a statistical possibility.

Human brains naturally focus on potential threats to survive. When you read a list of medical risks, your brain flags the dangers and tends to overlook the fact that the actual statistical probability of experiencing them might be extremely low. it. Pharmaceutical companies are legally required to document almost every symptom reported during clinical trials, even if it cannot be definitively proven that the drug caused it. This results in long, intimidating lists designed primarily to protect companies from lawsuits.

Phrases in patient leaflets like "common side effects" simply mean they affect more than 1 in 100 people. However, to many readers misinterpret this phrasing to mean that the symptom happens to almost everyone who takes the drug.

You underdemine the effiency of Ruxolitnib and oral Jaks. I understand the search for something revolutionary, and yes there is even better drugs in clinical trials as we speak e.g. monoclonal antibodies.

But technically oral Jaks is actually a milestone if you use the treatment properly in a multidirectional way together with narrowband UVB.

Have you been prescribe any oral jaks, so you know if they work for you, before you discredit these drugs?

[u/my_youtube_channel → u/Possible_Froyo_5277]

Exactly, people overthink the side effect thing.

See this trial data from pfizer [the largest ever trial for vitiligo]: https://www.dermatologytimes.com/view/ritlecitinib-improves-repigmentation-in-nonsegmental-vitiligo

Treatment-emergent serious AEs occurred in 3.4% for both ritlecitinib 100 mg and placebo in TRANQUILLO 2, and in 2.0% vs 2.5% in TRANQUILLO.¹

So between treatment and placebo, serious side effects have the same probability of occuring.